ClinicalTrials.Veeva

Menu

Hysteroscopic Tubal Occlusion Using Amacrylate With or Without Lipidol in Patients With Hydrosalpinx Prior to IVF

A

Ain Shams University

Status and phase

Not yet enrolling
Phase 3

Conditions

Effectiveness of Isoamyl-2-cyanoacrylate With and Without Ethiodized Oil in Occluding Hydrosalpinx Prior to IVF

Treatments

Drug: iso-amyl- 2-cyanoacrylate.
Drug: iso-amyl- 2-cyanoacrylate mixed with Ethiodized oil

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Hysteroscopic tubal occlusion using iso-amyl- 2-cyanoacrylate with or without Ethiodized oil (Lipidol) in patients with hydrosalpinx prior to IVF

Full description

hysteroscopic injection of iso-amyl- 2-cyanoacrylate with or without Ethiodized oil (Lipidol) in patients with hydrosalpinx requiring IVF. after one months and two months of the primary injection hysterosalpingography will be done to test for tubal occlusion.

Enrollment

45 estimated patients

Sex

Female

Ages

25 to 43 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: • Infertile women due to tubal factor with hydrosalpinx (unilateral or bilateral) prepared for IVF

Exclusion Criteria:

  • • Any patient with acute pelvic inflammatory disease, endometritis, lower genital tract infection.

    • The presence of intrauterine synechiae that might hinder the proper hysteroscopic examination and tubal cannulation diagnosed by diagnostic hysteroscopy.
    • The presence of uterine anomalies that might hinder the proper hysteroscopic examination and tubal cannulation diagnosed by diagnostic hysteroscopy.
    • Undiagnosed genital bleeding.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

45 participants in 2 patient groups

Hysteroscopic tubal occlusion using iso-amyl- 2-cyanoacrylate mixed with Ethiodized oil
Active Comparator group
Description:
Group 2 including 20 patients with hydrosalpinx refaired for hysteroscopic tubal occlusion prior to IVF using iso-amyl- 2-cyanoacrylate mixed with Ethiodized oil.
Treatment:
Drug: iso-amyl- 2-cyanoacrylate mixed with Ethiodized oil
Hysteroscopic tubal occlusion using only iso-amyl- 2-cyanoacrylate
Active Comparator group
Description:
Group 1 including 25 patients with hydrosalpinx refaired for hysteroscopic tubal occlusion prior to IVF using iso-amyl- 2-cyanoacrylate .
Treatment:
Drug: iso-amyl- 2-cyanoacrylate.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems